Skip to main content
The Markets by Proactive
Go to Proactive Australia

Archive

Xphyto Therapeutics rapid point of care COVID-19 test now available for sale in Germany

Xphyto Therapeutics rapid point of care COVID-19 test now available for sale in Germany

XPhyto Therapeutics (CSE: XPHY – OTC: XPHYF) CEO Hugh Rogers joined Steve Darling from Proactive to share news their partner, Max Pharma will launch the sale of its 25-minute PCR test system in Germany next week.

Rogers talks about this milestone for the company and this product is expected to fill the market gap between disposable antigen tests and centralized automated PCR systems.